Investing.com - Laboratory America reported on Wednesday first quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Laboratory America announced earnings per share of $2.37 on revenue of $2.82B. Analysts polled by Investing.com anticipated EPS of $2.22 on revenue of $2.82B. That with comparison to EPS of $2.62 on revenue of $2.79B in the same period a year before.Laboratory America had reported EPS of $2.86 on revenue of $2.95B in the previous quarter.Analysts are expecting EPS of $0.99 and revenue of $2.48B in the upcoming quarter.
Laboratory America shares are up 4% from the beginning of the year and are trading at $175.96 , down-from-52-week-high.They are outperforming the S&P 500 which is down 11.75% year to date.
Laboratory America follows other major Healthcare sector earnings this month
Laboratory America's report follows an earnings beat by J&J on April 14, who reported EPS of $2.3 on revenue of $20.69B, compared to forecasts EPS of $2.02 on revenue of $19.73B.
Novartis ADR had beat expectations on Tuesday with first quarter EPS of $1.56 on revenue of $12.28B, compared to forecast for EPS of $1.37 on revenue of $11.99B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar